167 related articles for article (PubMed ID: 23617709)
21. TROP-2 expression in papillary thyroid cancer: a preliminary cyto-histological study.
Addati T; Achille G; Centrone M; Petroni S; Popescu O; Russo S; Grammatica L; Simone G
Cytopathology; 2015 Oct; 26(5):303-11. PubMed ID: 25164548
[TBL] [Abstract][Full Text] [Related]
22. Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility.
Schmitt AC; Cohen C; Siddiqui MT
Cancer Cytopathol; 2010 Aug; 118(4):196-202. PubMed ID: 20731005
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19.
Murtezaoglu AR; Gucer H
Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974
[TBL] [Abstract][Full Text] [Related]
24. GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland.
Nikiforova MN; Nikitski AV; Panebianco F; Kaya C; Yip L; Williams M; Chiosea SI; Seethala RR; Roy S; Condello V; Santana-Santos L; Wald AI; Carty SE; Ferris RL; El-Naggar AK; Nikiforov YE
Thyroid; 2019 Feb; 29(2):161-173. PubMed ID: 30648929
[TBL] [Abstract][Full Text] [Related]
25. Combined staining for immunohistochemical markers in the diagnosis of papillary thyroid carcinoma: improvement in the sensitivity or specificity?
Wu G; Wang J; Zhou Z; Li T; Tang F
J Int Med Res; 2013 Aug; 41(4):975-83. PubMed ID: 23857157
[TBL] [Abstract][Full Text] [Related]
26. Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine-like changes.
Mai KT; Bokhary R; Yazdi HM; Thomas J; Commons AS
Histopathology; 2002 Feb; 40(2):133-42. PubMed ID: 11952857
[TBL] [Abstract][Full Text] [Related]
27. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland.
Gaffney RL; Carney JA; Sebo TJ; Erickson LA; Volante M; Papotti M; Lloyd RV
Am J Surg Pathol; 2003 Apr; 27(4):494-8. PubMed ID: 12657934
[TBL] [Abstract][Full Text] [Related]
28. Hyalinizing trabecular tumour of the thyroid: fine-needle aspiration cytological diagnosis and correlation with histology.
Saglietti C; Piana S; La Rosa S; Bongiovanni M
J Clin Pathol; 2017 Aug; 70(8):641-647. PubMed ID: 28424236
[TBL] [Abstract][Full Text] [Related]
29. Hyalinizing trabecular tumor of the thyroid: a clinicopathological analysis of four cases and review of the literature.
Liu Y; Huang X; Hu Y; Wang F; Du T; He W; Chen L; Lang B; Pu Q; Chen H
Int J Clin Exp Pathol; 2017; 10(7):7616-7626. PubMed ID: 31966606
[TBL] [Abstract][Full Text] [Related]
30. Stromal tiny black dots, like "sugar-coated", of von Kossa stain is a diagnostic clue to hyalinizing trabecular tumor of the thyroid gland.
Hino R; Motoi N; Toda K; Ebina A; Yamada K; Higuchi M; Hirokawa M; Ishikawa Y
Pathol Int; 2018 Mar; 68(3):176-182. PubMed ID: 29368414
[TBL] [Abstract][Full Text] [Related]
31. HBME-1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma.
Nga ME; Lim GS; Soh CH; Kumarasinghe MP
Diagn Cytopathol; 2008 Aug; 36(8):550-6. PubMed ID: 18618720
[TBL] [Abstract][Full Text] [Related]
32. Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.
Ma H; Yan J; Zhang C; Qin S; Qin L; Liu L; Wang X; Li N
Int J Clin Exp Pathol; 2014; 7(11):7999-8007. PubMed ID: 25550843
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
Abouhashem NS; Talaat SM
Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
[TBL] [Abstract][Full Text] [Related]
34. Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma.
Mai KT; Landry DC; Thomas J; Burns BF; Commons AS; Yazdi HM; Odell PF
Histopathology; 2001 Jul; 39(1):25-32. PubMed ID: 11454041
[TBL] [Abstract][Full Text] [Related]
35. [Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].
He CN; He L; Cheng JQ; Chen SC; Zhao HF; Zhai JP; Zhang J
Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):35-9. PubMed ID: 18509983
[TBL] [Abstract][Full Text] [Related]
36. Hyaline matrix in hyalinizing trabecular tumor: Findings in fine-needle aspiration smears.
Bakuła-Zalewska E; Cameron R; Gałczyński JP; Domanski HA
Diagn Cytopathol; 2015 Sep; 43(9):710-3. PubMed ID: 25352467
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid.
Rossi ED; Raffaelli M; Mule' A; Miraglia A; Lombardi CP; Vecchio FM; Fadda G
Histopathology; 2006 Jun; 48(7):795-800. PubMed ID: 16722927
[TBL] [Abstract][Full Text] [Related]
38. Hyalinizing trabecular tumor of the thyroid: an update.
Nosé V; Volante M; Papotti M
Endocr Pathol; 2008; 19(1):1-8. PubMed ID: 17960500
[TBL] [Abstract][Full Text] [Related]
39. Associations Between Nucleus Size, and Immunohistochemical Galectin-3, Cytokeratine-19 and Hbme-1 Markers in Thyroid Papillary Carcinoma: A Morphometric Analyze.
Toy H; Etli O; Celik ZE; Sezgin Alikanoglu A
Pathol Oncol Res; 2019 Jan; 25(1):401-408. PubMed ID: 29150742
[TBL] [Abstract][Full Text] [Related]
40. [The morphological and immunohistochemical features and malignancy potential of a hyalinizing trabecular tumor of the thyroid].
Abrosimov AIu; Dvinskikh NIu; Makanin MA; mal'kov PG; Grinevich VN
Arkh Patol; 2009; 71(6):36-9. PubMed ID: 20131505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
